Aurobindo Pharma Gets Tentative US Approval For HIV Treatment
12 Mars 2009 - 7:18AM
Dow Jones News
India's Aurobindo Pharma Ltd. (524804.BY) said Thursday it has
received U.S. Food and Drug Administration's tentative approval to
sell generic lopinavir/ritonavir tablets.
The company said the approval is for lopinavir/ritonavir tablets
in 100/25-milligram and 200/50-mg doses. The drug is a generic
equivalent of Abbott Laboratories' (ABT) Kaletra tablets.
The tablets are indicated in combination with other
anti-retroviral agents for the treatment of HIV-1 infection in
adults and children above the age of two years, the company said in
a statement.
-By Rumman Ahmed, Dow Jones Newswires; 91-9845104173;
rumman.ahmed@dowjones.com